-
1
-
-
0028238589
-
Viral contamination of blood products
-
Thomas, D. (1994). Viral contamination of blood products. Lancet 343, 1583-1584.
-
(1994)
Lancet
, vol.343
, pp. 1583-1584
-
-
Thomas, D.1
-
3
-
-
0021140086
-
Stabilization of serum albumin to heat, and inactivation of the hepatitis virus
-
Edsall, J. T. (1984). Stabilization of serum albumin to heat, and inactivation of the hepatitis virus. Vox Sang. 46, 338-340.
-
(1984)
Vox Sang.
, vol.46
, pp. 338-340
-
-
Edsall, J.T.1
-
4
-
-
0003033999
-
Hepatitis A virus transmission by blood products
-
Prowse, C., Follett, E. and Prince, A. (1994). Hepatitis A virus transmission by blood products. Vox Sang. 67 S1, 1-86.
-
(1994)
Vox Sang.
, vol.67
-
-
Prowse, C.1
Follett, E.2
Prince, A.3
-
5
-
-
19144369629
-
Human parvovirus B19 and blood products
-
in press
-
Prowse, C., Ludlam, C. A. and Yap, P. L. (1996). Human parvovirus B19 and blood products. Vox Sang, (in press).
-
(1996)
Vox Sang
-
-
Prowse, C.1
Ludlam, C.A.2
Yap, P.L.3
-
6
-
-
0006268428
-
Viral inactivation of blood products
-
ed. by K. C. Anderson and P. M. Ness, Saunders, Philadelphia
-
Prudouz, K. N. and Fratantoni, J. C. (1994). Viral inactivation of blood products. In, Scientific Basis of Transfusion Medicine, ed. by K. C. Anderson and P. M. Ness, pp. 852-871. Saunders, Philadelphia.
-
(1994)
Scientific Basis of Transfusion Medicine
, pp. 852-871
-
-
Prudouz, K.N.1
Fratantoni, J.C.2
-
7
-
-
0026784825
-
Safety aspects in the manufacturing of plasma-derived coagulation factor concentrates
-
Burnouf, T. (1992). Safety aspects in the manufacturing of plasma-derived coagulation factor concentrates. Biologicals 20, 91-100.
-
(1992)
Biologicals
, vol.20
, pp. 91-100
-
-
Burnouf, T.1
-
8
-
-
19144362118
-
Virus safety of purified biological products for therapeutic use
-
ed. by D. L. Pyle, Royal Society of Chemistry, Cambridge
-
Roberts, P. L. (1994). Virus safety of purified biological products for therapeutic use. In, Separations for Biotechnology 3, ed. by D. L. Pyle, pp. 420-426. Royal Society of Chemistry, Cambridge.
-
(1994)
Separations for Biotechnology
, vol.3
, pp. 420-426
-
-
Roberts, P.L.1
-
9
-
-
0242511561
-
Procedures for the prevention of virus transmission by blood products
-
ed. by R. Madhok, C. D. Forbes and B. L. Evatt, Chapman and Hall, London
-
Foster, P. R. and Cuthbertson, B. (1994). Procedures for the prevention of virus transmission by blood products. In, Blood, Blood Products and HIV, ed. by R. Madhok, C. D. Forbes and B. L. Evatt, pp. 207-248. Chapman and Hall, London.
-
(1994)
Blood, Blood Products and HIV
, pp. 207-248
-
-
Foster, P.R.1
Cuthbertson, B.2
-
10
-
-
0027255828
-
Clinical evaluation of viral safety of coagulation factor VIII and IX concentrates
-
Mannucci, P. M. (1993). Clinical evaluation of viral safety of coagulation factor VIII and IX concentrates. Vox Sang. 64, 197-203.
-
(1993)
Vox Sang.
, vol.64
, pp. 197-203
-
-
Mannucci, P.M.1
-
11
-
-
0003082855
-
Viral contamination of human plasma and procedures for preventing virus transmission by plasma products
-
ed. by J. R. Harris, Wiley-Liss, New York
-
Cuthbertson, B., Reid, K. G. and Foster, P. R.(1991). Viral contamination of human plasma and procedures for preventing virus transmission by plasma products. In, Blood Separation and Plasma Fractionation, ed. by J. R. Harris, pp. 385-435. Wiley-Liss, New York.
-
(1991)
Blood Separation and Plasma Fractionation
, pp. 385-435
-
-
Cuthbertson, B.1
Reid, K.G.2
Foster, P.R.3
-
12
-
-
0028024550
-
Human parvovirus: Implications for transfusion medicine
-
Luban, N. L. C. (1994). Human parvovirus: implications for transfusion medicine. Transfusion 34, 821-827.
-
(1994)
Transfusion
, vol.34
, pp. 821-827
-
-
Luban, N.L.C.1
|